The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy

Journal of Muscle Research and Cell Motility

Volumn 18, Issue 3, 1997, Pages 275-283

  Cuda, Giovanni ^a   Fananapazir, Lameh ^a   Epstein, Neal D ^a   Sellers, James R ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MYOSIN HEAVY CHAIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE TRANSLOCATION; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE;

ACTINS; CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSINS;

EID: 0030976860     PISSN: 01424319     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018613907574     Document Type: Article

References (39)

1. ANAN, R., GREVE, G., THIERFELDER, L., WATKINS, H., MCKENNA, W. J., SOLOMON, S., VECCHIO, C., SHONO, H., NAKAO, S., TANAKA, H., MARES, A., JR., TOWBIN, J. A., SPIRITO, P., ROBERTS, R., SEIDMAN, J. G. & SEIDMAN, C. E. (1994) Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J. Clin. Invest. 93, 280-5.
2. BERGER, B., WILSON, D., WOLF, E., TONCHEV, T., MILLA, M. & KIM, P. (1995) Predicting coiled-coil by use of pairwise residue correlations. Proc. Natl Acad. Sci. USA 92, 8259-63.
3. BONNE, G., CARRIER, L., BERCOVICI, J., CRUAUD, C., RICHARD, P., HAINQUE, B., GAUTEL, M., LABEIT, S., JAMES, M., BECKMANN, J., WEISSENBACH, J., VOSBERG, H. P., FISZMAN, M., KOMAJDA, M. & SCHWARTZ, K. (1995) Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet. 11, 438-40.
4. CUDA, G., FANANAPAZIR, L., ZHU, W.-S., SELLERS, J. R. & EPSTEIN, N. D. (1993) Skeletal muscle expression and abnormal function of β-myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 91, 2861-5.
5. DAUSSE, E., KOMAJDA, M., FETLER, L., DUBOURG, O., DUFOUR, C., CARRIER, L., WISNEWSKY, C., BERCOVICI, J., HENGSTENBERG, C., AL-MAHDAWI, S., ISNARD, R., HAGEGE, A., BOUHOUR, J.-B., DESNOS, M., BECKMANN, J., WEISSENBACH, J., SCHWARTZ, K. & GUICHENEY, P. (1993) Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the β-myosin heavy chain gene. J. Clin. Invest. 92, 2807-13.
6. EISENBERG, E. & KIELLEY, W. W. (1974) Troponin-tropomyosin complex. J. Biol. Chem. 249, 4742-8.
7. Arg →Gln mutation. Circulation 86, 345-52.
8. EPSTEIN, N. D., FANANAPAZIR, L., LIN, H. J., WHITE, R., LALOUEL, J. M., NIENHUIS, A. & LEPPERT, M. (1992b) Evidence of genetic heterogeneity in five fimilies with familial hypertrophic cardiomyopathy. Circulation 85, 635-47.
9. FANANAPAZIR, L. & EPSTEIN, N. D. (1994) Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 89, 22-32.
10. FANANAPAZIR, L., DALAKAS, M. C., CYRAN, F., COHN, G. & EPSTEIN, N. D. (1993) Missense mutations in the β-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc. Natl Acad. Sci. USA 90, 3993-7.
11. FANANAPAZIR, L., MCAREAVEY, D. & EPSTEIN, N. D. (1994) Hypertrophic cardiomyopathy. In Electrophysiology, From Cell to Bedside (edited by ZIPES, D. & JALIFE, J.) pp. 769-79. Philadelphia: W. B. Saunders Co.
12. 4. Biochemistry 34, 8960-72.
13. GEISTERFER-LOWRANCE, A. A. T., KASS, S., TANIGAWA, G., VOSBERG, H.-P. MCKENNA, W., SEIDMAN, C. E. & SEIDMAN, J. G. (1990) A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 62, 999-1006.
14. HARRIS, D. E., WORK, S. S., WRIGHT, R. K., ALPERT, N. R. & WARSHAW, D. M. (1994) Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J. Muscle Res. Cell Motil. 15, 11-19.
15. HOMSHER, E., WANG, F. & SELLERS, J. R. (1992) Factors affecting movement of F-actin filaments propelled by skeletal muscle heavy meromyosin. Am. J. Physiol. Cell Physiol. 262, C714-23.
16. KISHINO, A. & YANAGIDA, T. (1988) Force measurements by micromanipulation of a single actin filament by glass needles. Nature 334, 74-6.
17. KRAULIS, P. J. (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structure. J. Appl. Crystallogr. 24, 946-50.
18. KUBALEK, E. W., UYEDA, T. Q. P. & SPUDICH, J. A. (1996) a Dictyostelium myosin II lacking a proximal 58-kDa portion of the tail is functional in vitro and in vivo. Mol. Biol. Cell 3, 1455-62.
19. LANKFORD, E. B., EPSTEIN, N. D., FANANAPAZIR, L. & SWEENEY, H. L. (1995) Abnormal contractile properties of muscle fibres expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95, 1409-14.
20. MARGOSSIAN, S. S., KRUEGER, J. W., SELLERS, J. R., CUDA, G., CAULFIELD, J. B., NORTON, P. & SLAYTER, H. S. (1991) Influence of the cardiac myosin hinge region on contractile activity. Proc. Natl Acad. Sci. USA 88, 4941-5.
21. MCLACHLAN, A. D. (1984) Structural implications of the myosin amino acid sequence. Annu. Rev. Biophys. Bioeng. 13, 167-89.
22. MOOLMAN, J. C., BRINK, P. A. & CORFIELD, V. A. (1993) Identification of a new missense mutation at Arg403, a CpG mutation hotspot, in exon 13 of the β-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum. Mol. Genet. 2, 1731-2.
23. POETTER, K., JIANG, H., HASSANZADEH, S., MASTER, S. R., CHANG, A., DALAKAS, M. C., RAYMENT, I., SELLERS, J. R., FANANAPAZIR, L. & EPSTEIN, N. D. (1996) Mutations in either the essential or regulatory light chains are associated with a rare myopathy in human heart and skeletal muscle. Nature Gen. 13, 63-9.
24. RAYMENT, I., HOLDEN, H. M., WHITTAKER, M., YOHN, C. B., LORENZ, M., HOLMES, K. C. & MILLIGAN, R. A. (1993a) Structure of the actin-myosin complex and its implications for muscle contraction. Science 261, 58-65.
25. RAYMENT, I., RYPNIEWSKI, W. R., SCHMIDT-BäSE, K., SMITH, R., TOMCHICK, D. R., BENNING, M. M., WINKELMANN, D. A., WESENBERG, G. & HOLDEN, H. M. (1993b) Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261, 50-8.
26. RAYMENT, I., HOLDEN, H. M., SELLERS, J. R., FANANAPAZIR, L. & EPSTEIN, N. D. (1995) Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc. Natl Acad. Sci. USA 92, 3864-8.
27. SCHWARTZ, K., CARRIER, L., GUICHENEY, P. & KOMAJDA, M. (1995) Molecular Basis of Familial Cardiomyopathies. Circulation 91, 532-40.
28. SELLERS, J. R. & GOODSON, H. V. (1995) Motor proteins 2: myosin. Protein Profile 2, 1323-423.
29. SELLERS, J. R., SPUDICH, J. A. & SHEETZ, M. P. (1985) Light chain phosphorylation regulates the movement of smooth muscle myosin on actin filaments. J. Cell Biol. 101, 1897-902.
30. SUGI, H., KOBAYASHI, T., CROSS, T., NOGUCHI, K., KARR, T. & HARRINGTON, W. F. (1992) Contraction characteristics and ATPase activity of skeletal muscle fibres in the presence of antibody to myosin subfragment 2. Proc. Natl. Acad. Sci. USA, 89, 6134-7.
31. SWEENEY, H. L., STRACESKI, A. J., LEINWAND, L. A., TIKUNOV, B. A. & FAUST, L. (1994) Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269, 1603-5.
32. TOYOSHIMA, Y. Y., KRON, S. J., MCNALLY, E. M., NIEBLING, K. R., TOYOSHIMA, C. & SPUDICH, J. A. (1987) Myosin subfragment-1 sufficient to move actin filaments in vitro. Nature 328, 536-9.
33. UMEMOTO, S. & SELLERS, J. R. (1990) Characterization of in vitro motility assays using smooth muscle and cytoplasmic myosins. J. Biol. Chem. 265, 14864-9.
34. VIKSTROM, K. L. & LEINWAND, L. A. (1996) Contractile protein mutations and heart disease. Current Opinion in Cell Biology 8, 97-105.
35. WARSHAW, D. M., DESROSIERS, J. M., WORK, S. S. & TRYBUS, K. M. (1990) Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro. J. Cell Biol. 111, 453-63.
36. WATKINS, H., ROSENZWEIG, A., HWANG, D.-S., LEVI, T., MCKENNA, W., SEIDMAN, C. E. & SEIDMAN, J. G. (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326, 1108-14.
37. WATKINS, H., CONNER, D., THIERFELDER, L., JARCHO, J. A., MACRAE, C., MCKENNA, W. J., MARON, B. J., SEIDMAN, J. G. & SEIDMAN, C. E. (1995a) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet. 11, 434-7.
38. WATKINS, H., MCKENNA, W. J., THIERFELDER, L., SUK, H. J., ANAN, R., O'DONOGHUE, A., SPIRITO, P., MATSUMORI, A., MORAVEC, C. S., SEIDMAN, J. G. & SEIDMAN, C. E. (1995b) Mutations in the genes for the cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332, 1058-64.
39. YAMASHITA, H., SUGIURA, S., SERIZAWA, T., SUGIMOTO, T., IIZUKA, M., KATAYAMA, E. & SHIMMEN, T. (1992) Sliding velocity of isolated rabbit cardiac myosin correlates with isozyme distribution. Am. J. Physiol. Heart Circ. Physiol. 263, H464-72.